## QBTS: D-Wave Quantum Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -8.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-15.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($18.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Jefferies initiates D-Wave Quantum stock with Buy rating, $45 target**
- Source: Investing.com | 20251216T091027 | Bullish | Relevance: 100%
- Jefferies has initiated coverage on D-Wave Quantum Inc. (NYSE: QBTS) with a "Buy" rating and a $45.00 price target, citing the company's strong position in the quantum computing market. The firm highlighted D-Wave's two-pronged roadmap, commercial traction with over 100 organizations, and a robust financial position entering 2026. This positive outlook is further supported by recent analyst upgrades from Evercore ISI, Benchmark, and Cantor Fitzgerald.

**2. D-Wave Quantum Inc (QBTS) Stock News Today: Analysts Boost Targets, Insider Selling Filings Hit, and What 2026 Forecasts Really Say (Dec. 15, 2025)**
- Source: ts2.tech | 20251215T211027 | Neutral | Relevance: 100%
- D-Wave Quantum Inc (QBTS) experienced significant intraday swings on December 15, 2025, with shares down 8% after analyst upgrades from Mizuho ($46 target) and Evercore ISI ($44 target) contrasted with new insider selling filings. The company's Q3 2025 revenue was $3.7 million with a GAAP gross margin of 71.4%, and it recently formed a U.S. government business unit and completed warrant redemption. Investors are debating its high valuation against small revenue and potential for dilution, while gearing up for the Qubits 2026 conference in January.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Wedbush | $35 | $0 | 0% |
| 2025-12-16 | Jefferies | $45 | $0 | 0% |
| 2025-12-11 | Mizuho | $46 | $0 | 0% |
| 2025-12-03 | Evercore ISI Gr | $44 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Wedbush | init | Outperform |
| 2025-12-16 | Jefferies | init | Buy |
| 2025-12-11 | Mizuho | init | Outperform |
| 2025-12-03 | Evercore ISI Gr | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.09M) |
| Sells | 12 ($12.92M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 1 |

**Top Holders:**
- Vanguard Group Inc: 11.1% (+41.2%)
- Blackrock Inc.: 7.6% (+12.8%)
- Shaw D.E. & Co., Inc: 3.9% (+7.5%)
- UBS Group AG: 3.5% (+541.6%)
- Geode Capital Manage: 2.2% (+17.4%)

### Key Risks

1. Heavy insider selling: $13M sold (12 transactions in 90 days).
2. Elevated short interest (11.7%): bears positioning against stock.
3. Near-term weakness: 18.6% below SMA50 despite long-term uptrend.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.67 indicates undervaluation relative to growth. Balance sheet: strong liquidity (54.7x), low leverage (D/E 0.29). Revenue growth strong at 54% YoY. Insider selling cluster ($12.9M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.5B |
| Beta | 1.56 |
| 52W Range | $3.74 - $46.75 |
| Short Interest | 11.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.67 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 7.7% to -8.1% (-15.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 11.1pp (needs >3.0% for momentum thesis). Underperforming sector by 7.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.30x) but short-term weakness (below SMA20). RSI neutral at 45. OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -8.10% (CS: 4) | Weak |
| RSI_14 | 44.7 | Neutral |
| MACD Histogram | 0.14 | Bullish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.814x | Below |
| vs SMA200 | 1.299x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.78
- **Stop Loss:** $18.42 (22.5% risk)
- **Target:** $29.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 83
- **Position Value:** $1,973.74
- **Portfolio %:** 1.97%
- **Risk Dollars:** $450.00
- **Risk Per Trade:** 0.45%
- **Modifiers:** L1 90% | L2 50% | Combined 0.45x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-03-12 (Est: $-0.06)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.07 | $-0.05 | +24.5% |
| 2025Q2 | $-0.05 | $-0.08 | -47.4% |
| 2025Q1 | $-0.04 | $-0.03 | +16.9% |
| 2024Q4 | $-0.06 | $-0.08 | -25.0% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*